IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Dow AgroSciences LLC v Bayer Intellectual Property GmbH [2021] APO 13
Patent Application: 2017204231
Title:Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
Patent Applicant: Bayer Intellectual Property GmbH
Opponent:Dow AgroSciences LLC
Delegate:Dr Leslie F. McCaffery, Deputy Commissioner of Patents
Decision Date: 2 March 2021
Hearing Date: Written submissions completed on 5 January 2021
Catchwords: PATENTS – allowability of amendments under subsections 102(1) and 102(2) – disclosure by Markush formulae – whether the skilled person would learn something from the specification as proposed to be amended that they would not learn from the specification as filed – amendments allowable – opposition unsuccessful – costs awarded.
Representation: Solicitors for the applicant: Davies Collison Cave Law
Patent attorney for the applicant: Davies Collison Cave Pty Ltd
Counsel for the opponent: Craig Smith
Patent attorney for the opponent: FPA Patent Attorneys Pty Ltd
IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Patent Application: 2017204231
Title:Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
Patent Applicant: Bayer Intellectual Property GmbH
Date of Decision: 2 March 2021
DECISION
The opposition is unsuccessful.
Costs awarded against the opponent, Dow AgroSciences LLC.
REASONS FOR DECISION
Australian application 2017204231 (the application) was filed by Bayer Intellectual Property GmbH (the applicant) on 22 June 2017. It is a divisional application of AU2012288895 and claims the earliest priority date of 27 July 2011. The application was accepted on 13 November 2018 and a notice of opposition was filed by Dow AgroSciences LLC (the opponent) on 28 February 2019. Evidence in the substantive opposition was completed on 4 February 2020.
The applicant filed a statement of proposed amendments on 3 April 2020. A further statement of proposed amendments was filed on 4 May 2020 to correct some minor typographical errors in the first statement. The opponent filed a notice of opposition to the proposed amendments on 14 August 2020. On 21 October 2020, the delegate issued directions that the opposition proceed by way of written submissions, with the opponent having 4 weeks to file submissions in support of their opposition (referred to as DOS), the applicant then having 4 weeks to file submissions in answer (referred to as BOS), and the opponent then having 2 weeks to file submissions in reply (referred to as DOR). The submissions by the parties were completed on 5 January 2021.
The grounds of opposition
The grounds of opposition raised by the opponent are that the proposed amendments are not allowable under:
Subsection 102(1) because, as a result of the amendments, the claims would claim matter that extends beyond that disclosed in the complete specification.
Subsection 102(2)(b) because, as a result of the amendments, the specification would not comply with subsections 40(2)(a) and 40(3).
The relevant legislation
The application was filed on 22 June 2017, and the amendment of the Patents Act 1990…
Keep reading for free
Create a free CaseChat account to read Dow AgroSciences LLC v Bayer Intellectual Property GmbH and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2021] APO 13
- Decision Date
CaseChat Overview and Summary
The court found that the proposed amendments were allowable because they did not introduce any new subject matter beyond what was initially disclosed in the patent application. The amendments, specifically the clarification of Markush formulae, were deemed to enhance the understanding of the skilled person without adding information that was not already implicit in the original disclosure. The court concluded that the person skilled in the art would not gain any new knowledge from the amended specification that was not already discernible from the initial filing. Consequently, the opposition to the patent application was dismissed, and costs were awarded to Bayer Intellectual Property GmbH.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi